These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2572662)
21. Effect of atrial natriuretic peptide on acetylcholine-induced release of corticotropin-releasing factor from rat hypothalamus in vitro. Takao T; Hashimoto K; Ota Z Life Sci; 1988; 42(12):1199-203. PubMed ID: 2964553 [TBL] [Abstract][Full Text] [Related]
22. Specific up-regulation of CRH or AVP secretion by acetylcholine or lipopolysaccharide in inflammatory susceptible Lewis rat fetal hypothalamic cells. Wei R; Phillips TM; Sternberg EM J Neuroimmunol; 2002 Oct; 131(1-2):31-40. PubMed ID: 12458034 [TBL] [Abstract][Full Text] [Related]
23. Comparison of peptide release from fetal rat hypothalamic neurones cultured in defined media and serum-containing media. Clarke MJ; Gillies GE J Endocrinol; 1988 Mar; 116(3):349-56. PubMed ID: 2895160 [TBL] [Abstract][Full Text] [Related]
24. Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro. Tsagarakis S; Holly JM; Rees LH; Besser GM; Grossman A Endocrinology; 1988 Oct; 123(4):1962-9. PubMed ID: 2970959 [TBL] [Abstract][Full Text] [Related]
25. Interleukin-2 stimulates the secretion of arginine vasopressin but not corticotropin-releasing hormone from rat hypothalamic cells in vitro. Hillhouse EW Brain Res; 1994 Jul; 650(2):323-5. PubMed ID: 7953699 [TBL] [Abstract][Full Text] [Related]
26. Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin. Mozid AM; Tringali G; Forsling ML; Hendricks MS; Ajodha S; Edwards R; Navarra P; Grossman AB; Korbonits M Horm Metab Res; 2003 Aug; 35(8):455-9. PubMed ID: 12953161 [TBL] [Abstract][Full Text] [Related]
27. Production of corticotrophin releasing hormone by the isolated hypothalamus of the rat. Buckingham JC; Hodges JR J Physiol; 1977 Nov; 272(2):469-79. PubMed ID: 304104 [TBL] [Abstract][Full Text] [Related]
28. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response. Raber J; Koob GF; Bloom FE J Pharmacol Exp Ther; 1995 Feb; 272(2):815-24. PubMed ID: 7853199 [TBL] [Abstract][Full Text] [Related]
29. IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling. Raber J; Bloom FE J Neurosci; 1994 Oct; 14(10):6187-95. PubMed ID: 7523633 [TBL] [Abstract][Full Text] [Related]
30. Ontogeny and molecular weight of immunoreactive arginine vasopressin and corticotropin-releasing factor in the ovine fetal hypothalamus. Saoud CJ; Wood CE Peptides; 1996; 17(1):55-61. PubMed ID: 8822510 [TBL] [Abstract][Full Text] [Related]
31. Arginine vasopressin release by acetylcholine or norepinephrine: region-specific and cytokine-specific regulation. Raber J; Bloom FE Neuroscience; 1996 Apr; 71(3):747-59. PubMed ID: 8867047 [TBL] [Abstract][Full Text] [Related]
32. Interferon-alpha and transforming growth factor-beta 1 regulate corticotropin-releasing factor release from the amygdala: comparison with the hypothalamic response. Raber J; Koob GF; Bloom FE Neurochem Int; 1997; 30(4-5):455-63. PubMed ID: 9106261 [TBL] [Abstract][Full Text] [Related]
33. Proceedings: The effect of various putative neurotransmitters on the release of CRH from the hypophysiotrophic hypothalamus in vitro. Burden J; Hillhouse EW; Jones MT J Physiol; 1974 May; 239(1):51P-52P. PubMed ID: 4153021 [No Abstract] [Full Text] [Related]
34. Effect of bilateral adrenalectomy and corticosteroid therapy on the secretion of corticotrophin-releasing factor activity from the hypothalamus of the rat in vitro. Hillhouse EW; Jones MT J Endocrinol; 1976 Oct; 71(1):21-30. PubMed ID: 185314 [TBL] [Abstract][Full Text] [Related]
35. Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine corticotropin-releasing factor. 1. In vitro studies. Familari M; Smith AI; Smith R; Funder JW Neuroendocrinology; 1989 Aug; 50(2):152-7. PubMed ID: 2550836 [TBL] [Abstract][Full Text] [Related]
36. Biphasic inhibition of bioactive hypothalamic corticotrophin releasing factor secretion in vitro by corticosterone and prevention of the second phase by various steroids. Beckford U; Holmes MC; Gillham B; Jones MT J Endocrinol; 1983 Jun; 97(3):339-46. PubMed ID: 6602859 [TBL] [Abstract][Full Text] [Related]
37. In-vitro effects of corticosterone, synthetic ovine corticotrophin releasing factor and arginine vasopressin on the release of adrenocorticotrophin by fetal rat pituitary glands. Dupouy JP; Chatelain A J Endocrinol; 1984 Jun; 101(3):339-44. PubMed ID: 6327872 [TBL] [Abstract][Full Text] [Related]
38. The compartmentalized hypothalamo-neurohypophysial system: evidence for a neurohypophysial action of acetylcholine on vasopressin release. Gregg CM Neuroendocrinology; 1985 May; 40(5):423-9. PubMed ID: 2861580 [TBL] [Abstract][Full Text] [Related]
39. Ghrelin stimulates corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells. Kageyama K; Kumata Y; Akimoto K; Takayasu S; Tamasawa N; Suda T Stress; 2011 Sep; 14(5):520-9. PubMed ID: 21438782 [TBL] [Abstract][Full Text] [Related]
40. Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin 1 beta and alpha MSH: studies in rats with different susceptibility to inflammatory disease. Zelazowski P; Patchev VK; Zelazowska EB; Chrousos GP; Gold PW; Sternberg EM Brain Res; 1993 Dec; 631(1):22-6. PubMed ID: 8298992 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]